Panxiang Cao

477 total citations
32 papers, 255 citations indexed

About

Panxiang Cao is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Panxiang Cao has authored 32 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Molecular Biology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Panxiang Cao's work include Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (12 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Panxiang Cao is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (12 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Panxiang Cao collaborates with scholars based in China and United States. Panxiang Cao's co-authors include Yang Zhang, Xue Chen, Hongxing Liu, Fang Wang, Xiaoli Ma, Mingyu Wang, Wen Teng, Yu Zhang, Jiaqi Chen and Jiancheng Fang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Panxiang Cao

29 papers receiving 248 citations

Peers

Panxiang Cao

HEMAT

GENET

PHEOH

GENET

Meike Fischer Germany

Cécile K. Lopez France

Pierre Walrafen France

Magnus Tobiasson Sweden

Yuichiro Semba Japan

Andrea Inthal Austria

Marissa Rashkovan Canada

Mara Molkentin Germany

Yvonne Lisa Behrens Germany

Catherine Hélias France

Meike Fischer Germany

Panxiang Cao

137 ×0.9

HEMAT

167 ×1.3

33 ×0.6

GENET

85 ×1.7

PHEOH

22 ×0.6

GENET

Citations per year, relative to Panxiang Cao Panxiang Cao (= 1×) peers Meike Fischer

Countries citing papers authored by Panxiang Cao

Since Specialization

Citations

This map shows the geographic impact of Panxiang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panxiang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panxiang Cao more than expected).

Fields of papers citing papers by Panxiang Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panxiang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panxiang Cao. The network helps show where Panxiang Cao may publish in the future.

Co-authorship network of co-authors of Panxiang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Panxiang Cao. A scholar is included among the top collaborators of Panxiang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panxiang Cao. Panxiang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Jingjing, Maosheng Zhang, Da‐Le Guo, et al.. (2025). Diterpenoids from the bark of Torreya grandis and their cytotoxicity activity. Fitoterapia. 181. 106376–106376.

Liu, Deyan, Jiaqi Chen, Yu Luo, et al.. (2025). Clinical features and fusion gene analysis of two Torque Teno Mini virus associated acute promyelocytic leukemia cases. Annals of Hematology. 104(8). 4251–4255.

Chen, Xue, Lili Yuan, Xiaoli Ma, et al.. (2024). Successful treatment of the first adult case of ZMIZ1::ABL1-positive B cell lymphoblastic leukemia with dasatinib, chimeric antigen receptor T-cell therapy, and allogeneic hematopoietic stem cell transplantation. Cancer Genetics. 284-285. 16–19. 1 indexed citations

Cao, Panxiang, et al.. (2024). Lengthening of the CHURC1 3' untranslated region by alternative polyadenylation is associated with the progression of acute myeloid leukemia. Genes & Diseases. 12(1). 101248–101248. 1 indexed citations

Wang, Linya, Jiaqi Chen, Ying Wu, et al.. (2024). Case report of pediatric TTMV-related acute promyelocytic leukemia with central nervous system infiltration and rapid accumulation of RARA-LBD mutations. Heliyon. 10(5). e27107–e27107. 6 indexed citations

Zhou, Xiaosu, Xue Chen, Jiaqi Chen, et al.. (2023). The Ingenious Multiple Efficacies of the Integrated Gene Fragment of Torque Teno Mini Virus in Orchestrating Promyelocytic Leukemogenesis Via Hijacking Rara. Blood. 142(Supplement 1). 1576–1576. 2 indexed citations

Liu, Yang, Tong Wang, Hui Wang, et al.. (2022). Competitive evolved sub‐clonal BCR::ABL1 and novel MSI2:: PC fusion genes in myelodysplastic syndrome with isolated del(5q). Hematological Oncology. 41(1). 178–181. 2 indexed citations

Chen, Xue, Fang Wang, Yang Zhang, et al.. (2021). Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center. Blood Cancer Journal. 11(6). 112–112. 32 indexed citations

Zhang, Jing, Fang Wang, Lili Liu, et al.. (2021). Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies. Frontiers of Medicine. 16(3). 459–466. 5 indexed citations

10.

Zhang, Yang, Fang Wang, Xue Chen, et al.. (2021). Next‐generation sequencing reveals the presence of DDX41 mutations in acute lymphoblastic leukemia and aplastic anemia. SHILAP Revista de lepidopterología. 2(3). 508–513. 10 indexed citations

11.

Wang, Tong, Xue Chen, Ying Yin, et al.. (2020). Ectopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22)(p13;q12). Cancer Gene Therapy. 27(10-11). 810–818. 11 indexed citations

12.

Yan, Feng, Yaoyao Liu, Panxiang Cao, et al.. (2020). Estrogen-dependent MicroRNA-504 Expression and Related Baroreflex Afferent Neuroexcitation via Negative Regulation on KCNMB4 and KCa1.1 β4-subunit Expression. Neuroscience. 442. 168–182. 8 indexed citations

13.

Zhang, Jing, Fang Wang, Wei Zhang, et al.. (2020). Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies. BMC Medical Genetics. 21(1). 118–118. 5 indexed citations

14.

Liu, Hongxing, Jiaqi Chen, Fang Wang, et al.. (2020). NGS-Based Screening to Comprehensively Decipher TKIs Resistant Mutations in BCR-ABL1 Positive Leukemias. Blood. 136(Supplement 1). 30–30. 2 indexed citations

15.

Cao, Panxiang, Fang Wang, Jing Zhang, et al.. (2019). Analysis of overlapping heterozygous novel submicroscopic CNVs and FANCA–VPS9D1 fusion transcripts in a Fanconi anemia patient. Journal of Human Genetics. 64(9). 899–909. 8 indexed citations

16.

Chen, Xue, Fang Wang, Yang Zhang, et al.. (2019). A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide. British Journal of Cancer. 120(11). 1023–1025. 19 indexed citations

17.

Zhang, Yu, Yang Zhang, Fang Wang, et al.. (2019). The mutational spectrum of FLT3 gene in acute lymphoblastic leukemia is different from acute myeloid leukemia. Cancer Gene Therapy. 27(1-2). 81–88. 18 indexed citations

18.

Zhang, Yang, Fang Wang, Xue Chen, et al.. (2019). Companion gene mutations and their clinical significance in AML with double mutant CEBPA. Cancer Gene Therapy. 27(7-8). 599–606. 19 indexed citations

19.

Zhang, Yang, Fang Wang, Xue Chen, et al.. (2018). CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia. Cancer. 124(16). 3329–3338. 37 indexed citations

20.

Zhang, Yang, Fang Wang, Xue Chen, et al.. (2018). Mutation profiling of 16 candidate genes in de novo acute myeloid leukemia patients. Frontiers of Medicine. 13(2). 229–237. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact